2023年6月22日

3分鍾讀你能幫我解釋這個注意:Clivi,墨西哥公司專門從事糖尿病護理,籌集了1000萬美元的種子輪通過共同投資大陸的資本和基礎資本,與一群投資者的參與,包括國泰航空通過c .企業家創新基金,兩家企業,安靜的首都,500年,下十億投資,Conexo。healthtech公司計劃利用資本完成其產品和人工智能技術的發展,自動化功能,使醫生能夠增強他們的能力來治療病人。除了初始群投資者,天使投資者如裏卡多·韋德,創始人兼首席執行官Justor;Kueski Adalberto弗洛雷斯,創始人兼首席執行官;Suresh Batchu信任網絡的創始人之一;創始人兼首席執行官阿裏爾Lambrecht馬拉;塔拉Syed高管元;和雷納的創始人馬德裏,韋森特Aristegui和胡安·蒙特祖馬也加入進來。創始人兼首席執行官裏卡多Moguel Clivi,凸顯了短缺的內分泌學家在墨西哥,平均一個專家近10000名患者。這意味著病人隻能看醫生每隔三個月,盡管慢性疾病如糖尿病,每天都需要決策。 Aware of this need, Clivi has developed a platform that combines the human aspect with technology, connecting patients with endocrinologists, nutritionists, and psychologists. Furthermore, users can access monitoring and treatment plans through their preferred communication channel, such as WhatsApp, to improve their adherence to treatment goals and lifestyle changes. Clivi not only provides the necessary medical support but also supplies all the required equipment, such as glucose meters, test strips, blood testing kits, as well as the required medications. Since its launch in October 2021, Clivi’s platform has assisted thousands of patients and takes pride in achieving a 94% diabetes control rate within six months. Additionally, the company is experiencing steady growth, with an average of 2,000 new patients joining the platform each month. What are the implications for venture capital? Investment opportunities: The successful raising of US$10 million by Clivi indicates strong demand and potential in the diabetes healthcare sector. This may lead to an increased interest from venture capital firms to invest in startups and companies related to health and medical technology, particularly those addressing critical issues and presenting innovative solutions. Greater focus on digital health: Clivi’s investment in its artificial technology system to enhance patient care reinforces the importance of digital health and telemedicine. Venture capital firms may start prioritizing and seeking investment opportunities in startups offering digital solutions in the healthcare field, such as telemedicine platforms, health monitoring applications, and artificial intelligence technologies applied to healthcare. Strategic collaborations: The participation of multiple venture capital firms in Clivi’s funding round highlights the significance of strategic collaborations in the investment ecosystem. Venture capital firms may seek partnerships with other investment firms to share risks and expertise in specific areas of interest, such as healthcare. This collaboration can enable them to access larger investment opportunities and diversify their portfolios. What are the implications for Latin American healthtech startups? Increased investor interest: The successful fundraising of Clivi and its focus on diabetes care can generate increased investor interest in Latin American healthtech startups. This can lead to more funding opportunities and support for startups in the region. Validation of market potential: Clivi’s fundraising success and its efforts to address healthcare challenges in Mexico validate the market potential for healthtech startups in Latin America. This can inspire and encourage other startups to develop innovative solutions for healthcare issues prevalent in the region. Collaboration and knowledge sharing: The involvement of multiple investors in Clivi’s funding round highlights the importance of collaboration and knowledge sharing in the healthtech sector. Latin American healthtech startups can leverage this trend by seeking partnerships with established investors and industry players, which can provide valuable expertise, networks, and resources for their growth and development.